The Patent Finder

Genovoxx GmbH

Also on record
Records under this name other than patents Genovoxx GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Genovoxx GmbH

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,637,650Macromolecular Nucleotide Compounds and Methods for Using the Same
Formerly held
Term ended
Term ended Sep 9, 2026 · High confidence
Term endedTerm ended Sep 9, 2026High confidence
US 9,035,035Macromolecular Nucleotide Compounds and Methods for Using the Same
Formerly held
Term ended
Term ended Sep 9, 2026 · Medium confidence
Term endedTerm ended Sep 9, 2026Medium confidence
US 9,315,860Conjugates of nucleotides and method for the application thereof
Formerly held
Lapsed on the fee record
Ended Apr 19, 2024 · USPTO record
Lapsed on the fee recordEnded Apr 19, 2024USPTO record
US 9,994,894Method and components for detecting nucleic acid chains
Formerly held
Lapsed on the fee record
Ended Jun 12, 2022 · USPTO record
Lapsed on the fee recordEnded Jun 12, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited